These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3686442)

  • 1. [Indications and effectiveness of combined therapy in chronic glomerulonephritis].
    Ratner MIa; Biriukova LS; Makurov AI
    Ter Arkh; 1987; 59(8):29-34. PubMed ID: 3686442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged treatment of mesangioproliferative glomerulonephritis with a cytostatic agent and prednisolone and a combination of a cytostatic agent, prednisolone an anticoagulant and an antiaggregant].
    Ratner MIa; Tomilina NA; Klinkman Kh; Shmitt E; Kreger E
    Ter Arkh; 1980; 52(8):106-10. PubMed ID: 7256574
    [No Abstract]   [Full Text] [Related]  

  • 3. [The therapy of mesangiocapillary glomerulonephritis].
    Ratner MIa; Fedorova ND; Biriukova LS; Makurov AI
    Ter Arkh; 1995; 67(8):10-2. PubMed ID: 7482319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of treatment of glomerulonephritis with anticoagulants, antiaggregants, cytostatics and methindol].
    Riabov SI; Minkin RB; Rabukhina VA; Tarasova NA; Polenova IM
    Ter Arkh; 1978; 50(9):114-8. PubMed ID: 705640
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function.
    Savage JM; Postlethwaite RJ; Lendon M; Houston IB; Evans DI
    Int J Pediatr Nephrol; 1982 Sep; 3(3):167-73. PubMed ID: 7141788
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of various clinico-morphological variants of chronic glomerulonephritis].
    Tomilina NA; Biriukova LS; Makurov AI; Ratner MIa
    Ter Arkh; 1983; 55(6):61-6. PubMed ID: 6612622
    [No Abstract]   [Full Text] [Related]  

  • 7. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
    Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
    Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic glomerulonephritis].
    Ratner MIa; Tomilina NA; Gordon RI; Smirnova MP; Samokhina NM
    Klin Med (Mosk); 1975 Aug; 53(8):92-9. PubMed ID: 1186099
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis].
    Kacprzyk F; Kubala L; Chrzanowski W; Pastuszko-Maryniarczyk T
    Pol Tyg Lek; 1987 Aug; 42(34):1046-9. PubMed ID: 3422838
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.
    Brown CB; Wilson D; Turner D; Cameron JS; Ogg CS; Chantler C; Gill D
    Lancet; 1974 Nov; 2(7890):1166-72. PubMed ID: 4139590
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term use of a combination of immunosuppressants, and antiaggregant and an anticoagulant in the treatment of glomerulonephritis].
    Ratner MIa; Tomilina NA; Serov VV
    Ter Arkh; 1979; 51(6):43-7. PubMed ID: 473049
    [No Abstract]   [Full Text] [Related]  

  • 12. Focal necrotizing glomerulonephritis.
    Johnson JR; McGovern VJ
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):749-68. PubMed ID: 4803316
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effectiveness of cocktail therapy in the early treatment of children with MPGN type I, with special regard to remarkable histological improvement].
    Tanizawa T; Miura K; Asada R; Matsukura H; Mase D; Inaba S; Tani M; Hara M; Higuchi A; Okada T
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):401-12. PubMed ID: 3747251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Criteria for the outcome of treatment of chronic glomerulonephritis and the evaluation of the effectiveness of current therapeutic methods].
    Ratner MIa; Tomilina NA; Samokhina NM
    Ter Arkh; 1978; 50(1):81-7. PubMed ID: 635805
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood coagulation in glomerulonephritis treated with heparin combined with prednisolone].
    Kozhomkulova BZh; Panchenko VM; Gilunova NI
    Klin Med (Mosk); 1979 Jul; 57(7):66-72. PubMed ID: 480887
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

  • 18. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
    Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
    Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of leukeran in the overall therapy of chronic glomerulonephritis in children].
    Sitnitskaia IG; Bagdasarova IV; Panchenko VI
    Pediatr Akus Ginekol; 1977 Dec; (6):7-9. PubMed ID: 343057
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combined immunosuppressive-cytostatic treatment on antibody-dependent cellular cytotoxicity of patients with chronic glomerulonephritis.
    Láng I; Fekete B; Kenéz B; Nagy ZK; Gergely P
    Acta Med Acad Sci Hung; 1977; 34(4):247-50. PubMed ID: 618056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.